10 岁镰状细胞病患儿应用局部冷却喷雾后发生血管阻塞性事件。
Topical Vapocoolant-Associated Vaso-occlusive Event in a 10-year-old with Sickle Cell Disease.
机构信息
Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois.
Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois.
出版信息
Pain Manag Nurs. 2021 Oct;22(5):631-633. doi: 10.1016/j.pmn.2021.04.008. Epub 2021 Jun 3.
Abstract
Vapocoolant sprays are convenient forms of cold temperature analgesia. These sprays may not be suitable for all patients with particular concern for patients with sickle cell disease. To prevent any further cases from occurring, we propose adding a more specific cautionary statement to the manufacturer guidelines. We also hope that medical personnel can help patients with sickle cell avoid topical and environmental cold temperature triggers for sickle vaso-occlusive pain and reduce the suffering in this rare disease.
摘要
冷雾喷剂是一种便捷的低温镇痛形式。然而，这些喷剂可能并不适合所有患者，尤其是镰状细胞病患者。为了防止此类事件再次发生，我们建议在制造商指南中添加更具体的警告说明。我们还希望医务人员能够帮助镰状细胞病患者避免局部和环境低温触发镰状细胞血管阻塞性疼痛，并减轻这种罕见疾病带来的痛苦。
相似文献
1
Topical Vapocoolant-Associated Vaso-occlusive Event in a 10-year-old with Sickle Cell Disease.
Pain Manag Nurs. 2021 Oct;22(5):631-633. doi: 10.1016/j.pmn.2021.04.008. Epub 2021 Jun 3.
2
Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
Clin Trials. 2016 Aug;13(4):409-16. doi: 10.1177/1740774516636573. Epub 2016 Mar 21.
3
Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
J Pain Palliat Care Pharmacother. 2018 Dec;32(4):201-207. doi: 10.1080/15360288.2019.1577938. Epub 2019 Mar 21.
4
Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
Pain Pract. 2016 Jul;16(6):680-7. doi: 10.1111/papr.12313. Epub 2015 May 26.
5
Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Pediatrics. 1994 Feb;93(2):310-5.
6
Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
Pain Pract. 2018 Jul;18(6):788-797. doi: 10.1111/papr.12674. Epub 2018 Feb 28.
7
Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Pediatr Blood Cancer. 2014 Apr;61(4):693-6. doi: 10.1002/pbc.24864. Epub 2013 Nov 19.
8
An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
J Emerg Nurs. 2021 Jan;47(1):40-49.e1. doi: 10.1016/j.jen.2020.06.001. Epub 2020 Aug 18.
9
The management of pain in sickle cell disease.
Pediatr Clin North Am. 1989 Aug;36(4):1029-45. doi: 10.1016/s0031-3955(16)36735-9.
10
A holistic approach to vaso-occlusive pain crisis in children with sickle cell disease.
J Holist Nurs. 1992 Mar;10(1):62-75. doi: 10.1177/089801019201000107.
本文引用的文献
1
Post-Transcriptional Genetic Silencing of to Treat Sickle Cell Disease.
N Engl J Med. 2021 Jan 21;384(3):205-215. doi: 10.1056/NEJMoa2029392. Epub 2020 Dec 5.
2
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5.
3
Cold urticaria - What we know and what we do not know.
Allergy. 2021 Apr;76(4):1077-1094. doi: 10.1111/all.14674. Epub 2020 Dec 24.
4
Raynaud's phenomenon.
Clin Med (Lond). 2020 Nov;20(6):580-587. doi: 10.7861/clinmed.2020-0754.
5
Recent Advances in the Treatment of Sickle Cell Disease.
Front Physiol. 2020 May 20;11:435. doi: 10.3389/fphys.2020.00435. eCollection 2020.
6
Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger?
J Clin Med. 2019 Oct 15;8(10):1690. doi: 10.3390/jcm8101690.
7
Genetic comparison of sickle cell anaemia cohorts from Brazil and the United States reveals high levels of divergence.
Sci Rep. 2019 Jul 26;9(1):10896. doi: 10.1038/s41598-019-47313-2.
8
Summer Camps for Children with Sickle Cell Disease.
Ochsner J. 2018 Winter;18(4):358-363. doi: 10.31486/toj.18.0045.
9
Vapocoolant spray versus placebo spray/no treatment for reducing pain from intravenous cannulation: A meta-analysis of randomized controlled trials.
Am J Emerg Med. 2018 Nov;36(11):2085-2092. doi: 10.1016/j.ajem.2018.03.068. Epub 2018 Mar 27.
10
Sickle cell disease.
Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10.
Zotero 插件